Xinzi

F-1/A amended

Range $4.00 to $6.00 · 3,750,000 shares

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering of 3,750,000 ordinary shares at an expected price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol XZ. The company operates through PRC subsidiaries, with risks tied to Chinese regulatory scrutiny, including the CSRC's Trial Measures and potential U.S. listing restrictions under the HFCA Act. The filing emphasizes uncertainties around regulatory approvals and the impact of PRC laws on operations and shareholder value.

F-1/A amended

Price $5.00 · Range $4.00 to $6.00 · 3,750,000 shares · Gross proceeds $18,750,000

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering (IPO) of 3,750,000 ordinary shares at an expected price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol XZ. The company operates through PRC subsidiaries, with no direct operations in the Cayman Islands. The filing highlights regulatory risks related to Chinese laws, including potential changes to foreign ownership rules, dividend restrictions, and compliance with U.S. securities regulations such as the Holding Foreign Companies Accountable Act (HFCA).

F-1/A amended

Range $4.00 to $6.00 · 3,750,000 shares

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering (IPO) of 3,750,000 ordinary shares at an expected price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol XZ. The company operates through PRC subsidiaries, with no direct operations in the Cayman Islands. The filing highlights risks related to Chinese regulatory changes, including potential restrictions on foreign ownership, cybersecurity reviews, and compliance with U.S. laws like the HFCA Act. The company must file with the CSRC under new regulations and faces uncertainties regarding approval for U.S. listings.

F-1/A amended

Range $4.00 to $6.00 · 3,750,000 shares

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering (IPO) of 3,750,000 ordinary shares at an expected price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol XZ. The company operates through PRC subsidiaries, with no direct operations in the Cayman Islands. The filing emphasizes risks related to Chinese regulatory scrutiny, including potential changes to foreign ownership rules, compliance with the CSRC's Trial Measures, and risks under the HFCA Act regarding auditor inspections.

F-1/A amended

Range $4.00 to $6.00 · 3,750,000 shares

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering (IPO) of 3,750,000 ordinary shares at an expected price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol XZ. The company operates through PRC subsidiaries and faces significant risks related to Chinese regulatory scrutiny, including potential changes in foreign ownership rules, cybersecurity reviews, and compliance with the Holding Foreign Companies Accountable Act (HFCA). The filing also highlights the dependency of the Cayman holding company on cash flows from PRC entities, which are subject to restrictions on dividend distributions and currency conversions.

F-1 filed

Range $4.00 to $6.00 · 1,500,000 shares

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering (IPO) of 1.5 million ordinary shares at an expected price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol XZ. The company operates through multiple PRC subsidiaries and is subject to significant regulatory risks, including Chinese government oversight, potential changes in foreign ownership rules, and the Holding Foreign Companies Accountable Act (HFCA) risks. The filing also highlights compliance with the CSRC's Trial Measures for overseas listings.

DRS/A amended

Xinzi, a Cayman Islands exempted company, filed a DRS/A registration statement on December 19, 2024, for an initial public offering of ordinary shares. The offering is contingent on Nasdaq Capital Market listing approval, with no assurance of success. The filing highlights increased regulatory scrutiny from Chinese authorities, including compliance with the CSRC's Trial Administrative Measures for overseas listings, requiring a CSRC filing within three business days. The company emphasizes risks related to PRC regulatory changes, foreign investment restrictions, and potential U.S. trading prohibitions under the HFCA Act.

DRS/A amended

Xinzi, a Cayman Islands exempted company, is preparing for its initial public offering (IPO) of ordinary shares on a firm commitment basis. The offering is contingent on listing on the Nasdaq Capital Market, with the company highlighting risks related to Chinese regulatory scrutiny, including the CSRC's Trial Measures and potential restrictions under the HFCA Act. The filing emphasizes the company's structure as a holding company with operations in the PRC, subject to risks from foreign ownership regulations and currency controls.

DRS/A amended

Xinzi, a Cayman Islands exempted company, is conducting an initial public offering (IPO) of ordinary shares, seeking to list on the Nasdaq Capital Market. The offering is contingent on Nasdaq approval, with no assurance of success. The company operates through PRC subsidiaries and faces regulatory risks due to Chinese government policies, including potential restrictions on foreign ownership and compliance with the Holding Foreign Companies Accountable Act (HFCA). The filing highlights risks related to PRC regulatory changes, dividend distribution limitations, and uncertainties around CSRC approval requirements.

DRS/A amended

Xinzi, a Cayman Islands exempted company, filed a DRS/A registration statement for an initial public offering of ordinary shares on a firm commitment basis. The offering is contingent on Nasdaq listing approval, with the company expecting to list under an unspecified symbol. The filing emphasizes risks related to Chinese regulatory scrutiny, including the CSRC's Trial Measures requiring filings and potential restrictions under the HFCA Act. The company operates through PRC subsidiaries, with no direct operations in the Cayman Islands.

DRS/A amended

Xinzi filed an amended draft registration statement (DRS/A) for its IPO, updating details about regulatory requirements and risks. The filing emphasizes the company's structure as a Cayman Islands holding company with operations in China, highlighting risks related to Chinese regulations, listing requirements, and potential U.S.-China regulatory conflicts. The amendment includes new disclosures about compliance with the CSRC's Trial Measures and risks under the HFCA Act.

DRS filed

Xinzi, a Cayman Islands exempted company, is preparing for its initial public offering (IPO) of ordinary shares under a firm commitment, with plans to list on the Nasdaq Capital Market. The offering is conditional on Nasdaq approval, and there is no prior public market for its shares. The company operates through PRC subsidiaries and faces risks related to Chinese regulatory changes, currency controls, and potential U.S. delisting under the HFCA Act. The filing is a confidential draft registration statement submitted under the JOBS Act.